Trials / Conditions / Postmenopausal Women With Osteoporosis

Postmenopausal Women With Osteoporosis

9 registered clinical trials studyying Postmenopausal Women With Osteoporosis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Wo NCT06898060	Qilu Pharmaceutical Co., Ltd.	Phase 3
Completed	Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmeno NCT05345691	Biocon Biologics UK Ltd	Phase 3
Completed	A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteopor NCT05338086	mAbxience Research S.L.	Phase 3
Completed	To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk NCT07028320	Shenzhen Salubris Pharmaceuticals Co., Ltd.	Phase 3
Completed	A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis NCT04757376	Celltrion	Phase 3
Completed	Study Investigating PK, PD, Efficacy, Safety, and Immunogenicity of Biosimilar Denosumab (GP2411) in Patients NCT03974100	Sandoz	Phase 3
Completed	Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteop NCT01631214	Amgen	Phase 3
Completed	Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis NCT01581320	Alvogen Korea	Phase 3
Completed	Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover NCT01249261	Warner Chilcott	Phase 3